Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
17
|
pubmed:dateCreated |
1992-7-23
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0755-4982
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
822
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1535146-Administration, Oral,
pubmed-meshheading:1535146-Adult,
pubmed-meshheading:1535146-Arthritis, Rheumatoid,
pubmed-meshheading:1535146-Biological Availability,
pubmed-meshheading:1535146-Humans,
pubmed-meshheading:1535146-Injections, Intramuscular,
pubmed-meshheading:1535146-Methotrexate
|
pubmed:articleTitle |
[Compared bioavailability of methotrexate administered orally or intramuscularly in rheumatoid arthritis].
|
pubmed:publicationType |
Letter,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|